USE OF CA-19-9 IN THE EARLY DETECTION OF RECURRENCES IN COLORECTAL-CANCER - COMPARISON WITH CEA

被引：46

作者：

FILELLA, X

MOLINA, R

PIQUE, JM

GARCIAVALDECASAS, JC

GRAU, JJ

NOVELL, F

ASTUDILLO, E

DELACY, A

DANIELS, M

BALLESTA, AM

机构：

[1] HOSP CLIN BARCELONA,DEPT GASTROENTEROL,BARCELONA,SPAIN

[2] HOSP CLIN BARCELONA,DEPT SURG,BARCELONA,SPAIN

[3] HOSP CLIN BARCELONA,DEPT ONCOL,BARCELONA,SPAIN

来源：

TUMOR BIOLOGY | 1994年 / 15卷 / 01期

关键词：

CA; 19-9; CEA; CANCER-ASSOCIATED ANTIGENS; COLORECTAL CANCER; FOLLOW-UP;

D O I：

10.1159/000217867

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA. An increase in CA 19-9 preceded clinical diagnosis of recurrence in 25% of 72 patients. The mean time between the rise in CA 19-9 and clinical diagnosis of relapse was 3.7 months (median 3). Sensitivity of CA 19-9 in the early diagnosis of recurrence was much lower than that obtained for CEA (75%). Only 1 patient had elevated CA 19-9 levels and normal CEA.

引用

页码：1 / 6

页数：6

共 50 条

[21] PROGNOSTIC VALUE OF COMBINATION ASSAYS FOR CEA AND CA-19-9 IN GASTRIC-CANCER
IKEDA, Y
OOMORI, H
KOYANAGI, N
MORI, M
KAMAKURA, T
MINAGAWA, S
TATEISHI, H
SUGIMACHI, K
ONCOLOGY, 1995, 52 (06) : 483 - 486
[22] CA-19-9 AND CA-50 IN THE DETECTION OF PANCREATIC-CANCER
BARONE, D
PAGANUZZI, M
PUGLIESE, V
ONETTO, M
MARRONI, P
ASTE, H
TUMOR BIOLOGY, 1987, 8 (06) : 322 - 322
[23] The role of CA-19-9, CA 242 and CEA tumor markers in digestive tract cancer diagnostics
Hasmik, Vahradyan
Hasmik, Harutyunyan
Qnarik, Aleqsanyan
CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S209 - S209
[24] CA-242, A NEW TUMOR-MARKER FOR PANCREATIC-CANCER - A COMPARISON WITH CA-19-9, CA-50 AND CEA
HAGLUND, C
LUNDIN, J
KUUSELA, P
ROBERTS, PJ
BRITISH JOURNAL OF CANCER, 1994, 70 (03) : 487 - 492
[25] CEA AND CA-19-9 IN BENIGN PULMONARY OR MEDIASTINAL CYSTIC LESIONS
UYAMA, T
MONDEN, Y
SUMITOMO, M
MIURA, K
KIMURA, S
JOURNAL OF SURGICAL ONCOLOGY, 1989, 41 (02) : 103 - 108
[26] RECOMBINANT INTERFERON-GAMMA LACKS ACTIVITY AGAINST METASTATIC COLORECTAL-CANCER BUT INCREASES SERUM LEVELS OF CA-19-9
OCONNELL, MJ
RITTS, RA
MOERTEL, CG
SCHUTT, AJ
SHERWIN, SA
CANCER, 1989, 63 (10) : 1998 - 2004
[27] CEA, CA-19-9 AND CA-125 IN ASCITES-FLUID FROM CANCER-PATIENTS
BHARGAVA, A
PETRELLI, N
PIVER, S
NEMOTO, T
DOUGLASS, H
TAKITA, H
KAE, L
BROWN, W
FITZPATRICK, J
CLINICAL CHEMISTRY, 1986, 32 (06) : 1122 - 1122
[28] CA242 and total antioxidant levels in comparison to CEA and CA 19-9 in colorectal cancer
Yasasever, V
Oral, EN
Camlica, H
Dalay, N
JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (01): : 27 - 32
[29] CEA and CA 19-9 as prognostic indexes in colorectal cancer
Forones, NM
Tanaka, M
HEPATO-GASTROENTEROLOGY, 1999, 46 (26) : 905 - 908
[30] THE RADIOIMMUNOASSAY OF CARBOHYDRATE ANTIGEN 19-9 - COMPARISON WITH CEA AND TPA IN THE FOLLOW-UP OF COLORECTAL-CANCER
TOMMASI, M
CAPPELLI, G
FUCINI, C
JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1983, 27 (02): : 201 - 201

← 1 2 3 4 5 →